Assembly Biosciences Stock Market Value
| ASMB Stock | USD 15.16 0.22 1.43% |
| Symbol | Assembly |
Assembly Biosciences Price To Book Ratio
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Assembly Biosciences. If investors know Assembly will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Assembly Biosciences listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (6.89) | Revenue Per Share 4.125 | Quarterly Revenue Growth (1.00) | Return On Assets (0.35) | Return On Equity (1.02) |
The market value of Assembly Biosciences is measured differently than its book value, which is the value of Assembly that is recorded on the company's balance sheet. Investors also form their own opinion of Assembly Biosciences' value that differs from its market value or its book value, called intrinsic value, which is Assembly Biosciences' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Assembly Biosciences' market value can be influenced by many factors that don't directly affect Assembly Biosciences' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Assembly Biosciences' value and its price as these two are different measures arrived at by different means. Investors typically determine if Assembly Biosciences is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Assembly Biosciences' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.
Assembly Biosciences 'What if' Analysis
In the world of financial modeling, what-if analysis is part of sensitivity analysis performed to test how changes in assumptions impact individual outputs in a model. When applied to Assembly Biosciences' stock what-if analysis refers to the analyzing how the change in your past investing horizon will affect the profitability against the current market value of Assembly Biosciences.
| 01/08/2023 |
| 12/28/2024 |
If you would invest 0.00 in Assembly Biosciences on January 8, 2023 and sell it all today you would earn a total of 0.00 from holding Assembly Biosciences or generate 0.0% return on investment in Assembly Biosciences over 720 days. Assembly Biosciences is related to or competes with Spero Therapeutics, Achilles Therapeutics, Instil Bio, CytomX Therapeutics, Nuvation Bio, and NextCure. Assembly Biosciences, Inc., a clinical-stage biotechnology company, discovers and develops therapeutic candidates for th... More
Assembly Biosciences Upside/Downside Indicators
Understanding different market momentum indicators often help investors to time their next move. Potential upside and downside technical ratios enable traders to measure Assembly Biosciences' stock current market value against overall market sentiment and can be a good tool during both bulling and bearish trends. Here we outline some of the essential indicators to assess Assembly Biosciences upside and downside potential and time the market with a certain degree of confidence.
| Downside Deviation | 3.58 | |||
| Information Ratio | 0.0094 | |||
| Maximum Drawdown | 20.82 | |||
| Value At Risk | (5.39) | |||
| Potential Upside | 8.88 |
Assembly Biosciences Market Risk Indicators
Today, many novice investors tend to focus exclusively on investment returns with little concern for Assembly Biosciences' investment risk. Other traders do consider volatility but use just one or two very conventional indicators such as Assembly Biosciences' standard deviation. In reality, there are many statistical measures that can use Assembly Biosciences historical prices to predict the future Assembly Biosciences' volatility.| Risk Adjusted Performance | 0.0215 | |||
| Jensen Alpha | 0.0402 | |||
| Total Risk Alpha | (0.06) | |||
| Sortino Ratio | 0.0114 | |||
| Treynor Ratio | 0.0612 |
Assembly Biosciences Backtested Returns
At this point, Assembly Biosciences is unstable. Assembly Biosciences secures Sharpe Ratio (or Efficiency) of 0.0216, which signifies that the company had a 0.0216% return per unit of risk over the last 3 months. We have found twenty-eight technical indicators for Assembly Biosciences, which you can use to evaluate the volatility of the firm. Please confirm Assembly Biosciences' Mean Deviation of 3.02, risk adjusted performance of 0.0215, and Downside Deviation of 3.58 to double-check if the risk estimate we provide is consistent with the expected return of 0.0957%. Assembly Biosciences has a performance score of 1 on a scale of 0 to 100. The firm shows a Beta (market volatility) of 1.03, which signifies a somewhat significant risk relative to the market. Assembly Biosciences returns are very sensitive to returns on the market. As the market goes up or down, Assembly Biosciences is expected to follow. Assembly Biosciences right now shows a risk of 4.43%. Please confirm Assembly Biosciences semi variance, rate of daily change, and the relationship between the value at risk and kurtosis , to decide if Assembly Biosciences will be following its price patterns.
Auto-correlation | -0.74 |
Almost perfect reverse predictability
Assembly Biosciences has almost perfect reverse predictability. Overlapping area represents the amount of predictability between Assembly Biosciences time series from 8th of January 2023 to 3rd of January 2024 and 3rd of January 2024 to 28th of December 2024. The more autocorrelation exist between current time interval and its lagged values, the more accurately you can make projection about the future pattern of Assembly Biosciences price movement. The serial correlation of -0.74 indicates that around 74.0% of current Assembly Biosciences price fluctuation can be explain by its past prices.
| Correlation Coefficient | -0.74 | |
| Spearman Rank Test | -0.67 | |
| Residual Average | 0.0 | |
| Price Variance | 4.21 |
Assembly Biosciences lagged returns against current returns
Autocorrelation, which is Assembly Biosciences stock's lagged correlation, explains the relationship between observations of its time series of returns over different periods of time. The observations are said to be independent if autocorrelation is zero. Autocorrelation is calculated as a function of mean and variance and can have practical application in predicting Assembly Biosciences' stock expected returns. We can calculate the autocorrelation of Assembly Biosciences returns to help us make a trade decision. For example, suppose you find that Assembly Biosciences has exhibited high autocorrelation historically, and you observe that the stock is moving up for the past few days. In that case, you can expect the price movement to match the lagging time series.
Current and Lagged Values |
| Timeline |
Assembly Biosciences regressed lagged prices vs. current prices
Serial correlation can be approximated by using the Durbin-Watson (DW) test. The correlation can be either positive or negative. If Assembly Biosciences stock is displaying a positive serial correlation, investors will expect a positive pattern to continue. However, if Assembly Biosciences stock is observed to have a negative serial correlation, investors will generally project negative sentiment on having a locked-in long position in Assembly Biosciences stock over time.
Current vs Lagged Prices |
| Timeline |
Assembly Biosciences Lagged Returns
When evaluating Assembly Biosciences' market value, investors can use the concept of autocorrelation to see how much of an impact past prices of Assembly Biosciences stock have on its future price. Assembly Biosciences autocorrelation represents the degree of similarity between a given time horizon and a lagged version of the same horizon over the previous time interval. In other words, Assembly Biosciences autocorrelation shows the relationship between Assembly Biosciences stock current value and its past values and can show if there is a momentum factor associated with investing in Assembly Biosciences.
Regressed Prices |
| Timeline |
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.When determining whether Assembly Biosciences offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Assembly Biosciences' financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Assembly Biosciences Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Assembly Biosciences Stock:Check out Assembly Biosciences Correlation, Assembly Biosciences Volatility and Assembly Biosciences Alpha and Beta module to complement your research on Assembly Biosciences. For information on how to trade Assembly Stock refer to our How to Trade Assembly Stock guide.You can also try the Transaction History module to view history of all your transactions and understand their impact on performance.
Assembly Biosciences technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.